News Consun Pharmaceutical Group Limited

Stocks

1681

KYG2524A1031

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 06:08:30 11/06/26 pm AEST			5-day change	1st Jan Change
13.80 ^HKD	-0.79%		-3.70%	-11.76%

08/06	Consun Pharmaceutical Unit to Acquire 30% Stake in Supplier	MT
29/05	Consun Pharmaceutical Group Limited commences an Equity Buyback Plan for 84,120,311 shares, representing 10% of its issued share capital, under the authorization approved on May 26, 2026.	CI

All News

Mentions Relevance

08/06	Consun Pharmaceutical Unit to Acquire 30% Stake in Supplier	MT
29/05	Consun Pharmaceutical Group Limited commences an Equity Buyback Plan for 84,120,311 shares, representing 10% of its issued share capital, under the authorization approved on May 26, 2026.	CI
28/05	Consun Pharma Launches HK$200 Million Share Buyback Program; Shares Slip 3%	MT
28/05	Consun pharmaceutical group announces share repurchase program up to HKD200 million	RE
26/05	Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2025	CI
26/05	Consun Pharmaceutical Group Limited's Equity Buyback announced on June 16, 2025, has expired.	CI
27/03	Consun Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
26/03	Consun pharmaceutical logs FY revenue RMB 3,420 mln	RE
26/03	Consun Pharma's Profit Climbs 18% in 2025	MT
26/03	Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2025, Payable on or Around 22 June 2026	CI
29/01	Consun Pharma Expands Share Buyback Program to HK$300 Million	MT
07/11	Consun Pharmaceutical Proposes Share Award Scheme to Incentivize Staff; Shares Slip 2%	MT
25/09/25	Consun Pharmaceutical says executive director Zhu Quan redesignated as non-executive director	RE
25/09/25	Consun Pharmaceutical Group says Zhu Quan redesignated as a non-executive director	RE
25/09/25	Consun Pharmaceutical Group Limited Announces Redesignation of Zhu Quan from Executive Director to Non-Executive Director, Effective 25 September 2025	CI
20/08/25	Consun Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2025	CI
19/08/25	Consun Pharmaceutical Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2025 , Payable on September 19, 2025	CI
19/08/25	Consun Pharmaceutical Group's H1 Profit Jumps 25%	MT
19/08/25	Tranche Update on Consun Pharmaceutical Group Limited's Equity Buyback Plan announced on June 16, 2025.	CI
04/08/25	Consun Pharmaceutical says Horogos Consun subscribes wealth product for RMB252 million	RE
20/06/25	Consun Pharmaceutical Group Limited Announces Nomination Committee Changes, Effective from 20 June 2025	CI
16/06/25	Consun Pharmaceutical Group Limited commences an Equity Buyback for 85,126,334 shares, representing 10% of its issued share capital, under the authorization approved on June 16, 2025.	CI
13/06/25	Consun Pharmaceutical To Implement Share Repurchase Program Of Up To HKD200 Million	RE
22/05/25	Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2024	CI
13/05/25	Consun Pharmaceutical's FY 24 results reflect business resilience